Cutivate Generic Name & Formulations
Fluticasone propionate 0.05%; lotion.
Crm, oint—contact supplier; Lotion—120mL
Cutivate Dosage and Administration
Adults and Children
<1yr: not established. ≥1yr: apply a thin film to affected areas once daily for up to max 4 weeks; discontinue when control is achieved. Do not occlude.
Cutivate Boxed Warnings
Avoid use near eyes, on face, groin, or axillae. Do not use for diaper dermatitis, rosacea, perioral dermatitis, or on pre-existing skin atrophy. Avoid tight-fitting diapers or plastic pants. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, or reduce dose or potency if occurs. Treat infection if present; discontinue if infection persists or worsens. Lotion: avoid excessive sun exposure. Reevaluate periodically. Pregnancy. Nursing mothers: avoid direct infant exposure.
Cutivate Adverse Reactions
Burning, stinging, pruritus, irritation, folliculitis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infections, skin atrophy, striae, miliaria, erythema, dry skin, excoriation; HPA axis suppression (esp. in children); ophthalmic reactions (eg, cataracts, glaucoma).
Cutivate Clinical Trials
Cutivate Patient Counseling